Sanctioned measure expands rights of workers and establishes new rules for the cannabis sector

Projects approved in the state Senate seek to classify excessive cannabis smoke or odor as a public nuisance, even when consumption occurs on private properties

Study with over 28,000 people in 13 states in the US analyzes how the legalization of cannabis may influence opioid consumption among injectable drug users

Measures raise import costs and increase volatility for operators and suppliers in the sector in the United States

Project coordinated by Cannect, with participation of a researcher from HC of USP and Santa Casa de São Paulo, gathers data from 2,500 patients to expand evidence on the impacts of medicinal cannabis on human health

Survey by the Texas Politics Project indicates disapproval outweighs approval in the evaluation of state policies on cannabis and THC

An event that brings together policymakers, investors, and industry leaders is consolidating itself as the main strategic forum for legal cannabis in Europe and anticipates the market’s direction in 2026.

Free event takes place on March 28th at Parque Oriental, bringing together experts, associations, government officials, and the community to discuss access to medical cannabis, public policies, and development in ABC Paulista

Bill introduced in the state Legislature proposes adult use, medical program, and new rules for hemp-derived products

Entrepreneur Joaquim Castro states that the advancement of national cultivation and the review of RDC 660 will be decisive for prices, competition, importation, and patient access in Brazil

International clinical study and decision of the TJ-SP reinforce the debate on the use of medicinal cannabis in the treatment of fibromyalgia and broaden the discussion on access to cannabidiol in Brazil

The Federal University of Rio Grande do Norte (UFRN) has become the first institution in Brazil authorized by Anvisa to carry out controlled cultivation and processing of cannabis for scientific research. The planting takes place in an indoor system at the Brain Institute (ICe-UFRN), focusing on studies on epilepsy, autism, pain, sleep, and other neurological disorders

Tax changes, local regulations, and operational requirements have increased costs and delayed the opening of cannabis stores in the United States

Estudos publicados nos Estados Unidos e no Reino Unido indicam que o uso de cannabis pode afetar o cérebro de forma distinta na vida adulta e no envelhecimento

Studies published in the United States and the United Kingdom indicate that cannabis use may affect the brain differently in adulthood and aging

Episode addresses the update of RDC 660, international certification, and challenges to expand access to treatments with different cannabinoids in Brazil.

The process may pave the way for a dispensary in 2026 and highlights the contrast between tribal regulatory agility and the state's impasse over medical cannabis.

Scientific work suggests that the imbalance of the endocannabinoid system may be associated with depression in adolescence

In an interview with the CB.Poder program of Correio Brasiliense, conducted by journalists Adriana Bernardes and Sibele Negromonte, Leandro Safatle, acting CEO of Anvisa, detailed the behind-the-scenes and expectations regarding the new regulation of medicinal cannabis and research in Brazil

Biological understanding, clinical applications, and public policies show why the plant should be treated as a therapeutic resource — not just as a recreational or harmful substance